Mirabella Financial Services’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-32,510
Closed -$323K 479
2023
Q1
$323K Buy
32,510
+11,652
+56% +$82.4K 0.05% 271
2022
Q4
$145K Buy
+20,858
New +$119K 0.01% 334
2021
Q1
Sell
-20,615
Closed -$141K 272
2020
Q4
$141K Sell
20,615
-2,913
-12% -$20.5K 0.02% 271
2020
Q3
$174K Buy
+23,528
New +$152K 0.02% 294

Other funds holding ALDX

Mirabella Financial Services's ALDX Position: Q2 2023 in Review

Mirabella Financial Services sold out of Aldeyra Therapeutics (ALDX) in Q2 2023, closing a stake of 32,510 shares — an estimated $323K sold.

Mirabella Financial Services first reported a position in ALDX in Q3 2020 and held it in 4 quarters. The position peaked at $323K in Q1 2023. 119 funds tracked by Wall St. Rank hold ALDX as of Q2 2023.

  • Mirabella Financial Services reported no remaining Aldeyra Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Mirabella Financial Services sold 32,510 Aldeyra Therapeutics shares in Q2 2023, an estimated $323K.
  • Mirabella Financial Services first reported a position in Aldeyra Therapeutics in Q3 2020 and held it in 4 quarters.
  • Mirabella Financial Services's Aldeyra Therapeutics position peaked at $323K in Q1 2023.
  • 119 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2023.

Based on Mirabella Financial Services's 13F filing for Q2 2023, filed 7 Aug 2023.